Cargando…

Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study

BACKGROUND: Chronic infection by Trypanosoma cruzi could cause heart conduction disturbances. We sought to analyze electrocardiographic abnormalities among children with chronic T. cruzi infection with and without trypanocidal treatment with benznidazole. METHODOLOGY/PRINCIPAL FINDINGS: We studied 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Colantonio, Lisandro D., Prado, Nilda, Segura, Elsa L., Sosa-Estani, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861278/
https://www.ncbi.nlm.nih.gov/pubmed/27158908
http://dx.doi.org/10.1371/journal.pntd.0004651
_version_ 1782431195137572864
author Colantonio, Lisandro D.
Prado, Nilda
Segura, Elsa L.
Sosa-Estani, Sergio
author_facet Colantonio, Lisandro D.
Prado, Nilda
Segura, Elsa L.
Sosa-Estani, Sergio
author_sort Colantonio, Lisandro D.
collection PubMed
description BACKGROUND: Chronic infection by Trypanosoma cruzi could cause heart conduction disturbances. We sought to analyze electrocardiographic abnormalities among children with chronic T. cruzi infection with and without trypanocidal treatment with benznidazole. METHODOLOGY/PRINCIPAL FINDINGS: We studied 111 children 6–16 years of age with asymptomatic chronic T. cruzi infection who were recruited in 1991–1992 in Salta, Argentina. Most children were randomly assigned to benznidazole 5 mg/Kg/day (n = 47) or matching placebo (n = 48) for 60 days. Remaining children (n = 16) received treatment with benznidazole 5 mg/Kg/day open-label. Electrocardiograms were obtained at baseline and in 1995–1996, 1998, 2000 and 2005, and were analyzed using the Buenos Aires method. Among the 94 children with an electrocardiogram at baseline, 8 (8.5%) had electrocardiographic abnormalities, including 4 (4.7%) children with right bundle branch block. Proportion of abnormal electrocardiograms in the full population (n = 111) remained constant over time (media follow-up 8.6 years). Multivariable adjusted prevalence ratios (95% confidence interval [95%CI]) for electrocardiographic abnormalities in 1995–1996, 1998, 2000 and 2005 comparing children treated with benznidazole versus those not treated were 2.76 (0.66, 11.60), 2.33 (0.44, 12.31), 3.06 (0.48, 19.56), and 1.94 (0.33, 11.25), respectively. Among the 86 children with a normal electrocardiogram at baseline, 16 (18.6%) developed electrocardiographic abnormalities during follow-up. The multivariable adjusted hazard ratio for incident electrocardiographic abnormalities comparing children treated with benznidazole versus those not treated was 0.68 (95%CI: 0.25, 1.88). CONCLUSIONS/SIGNIFICANCE: Electrocardiographic abnormalities are frequent among children with chronic T. cruzi infection. Treatment with benznidazole for 60 days may not be associated with less electrocardiographic abnormalities.
format Online
Article
Text
id pubmed-4861278
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48612782016-05-13 Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study Colantonio, Lisandro D. Prado, Nilda Segura, Elsa L. Sosa-Estani, Sergio PLoS Negl Trop Dis Research Article BACKGROUND: Chronic infection by Trypanosoma cruzi could cause heart conduction disturbances. We sought to analyze electrocardiographic abnormalities among children with chronic T. cruzi infection with and without trypanocidal treatment with benznidazole. METHODOLOGY/PRINCIPAL FINDINGS: We studied 111 children 6–16 years of age with asymptomatic chronic T. cruzi infection who were recruited in 1991–1992 in Salta, Argentina. Most children were randomly assigned to benznidazole 5 mg/Kg/day (n = 47) or matching placebo (n = 48) for 60 days. Remaining children (n = 16) received treatment with benznidazole 5 mg/Kg/day open-label. Electrocardiograms were obtained at baseline and in 1995–1996, 1998, 2000 and 2005, and were analyzed using the Buenos Aires method. Among the 94 children with an electrocardiogram at baseline, 8 (8.5%) had electrocardiographic abnormalities, including 4 (4.7%) children with right bundle branch block. Proportion of abnormal electrocardiograms in the full population (n = 111) remained constant over time (media follow-up 8.6 years). Multivariable adjusted prevalence ratios (95% confidence interval [95%CI]) for electrocardiographic abnormalities in 1995–1996, 1998, 2000 and 2005 comparing children treated with benznidazole versus those not treated were 2.76 (0.66, 11.60), 2.33 (0.44, 12.31), 3.06 (0.48, 19.56), and 1.94 (0.33, 11.25), respectively. Among the 86 children with a normal electrocardiogram at baseline, 16 (18.6%) developed electrocardiographic abnormalities during follow-up. The multivariable adjusted hazard ratio for incident electrocardiographic abnormalities comparing children treated with benznidazole versus those not treated was 0.68 (95%CI: 0.25, 1.88). CONCLUSIONS/SIGNIFICANCE: Electrocardiographic abnormalities are frequent among children with chronic T. cruzi infection. Treatment with benznidazole for 60 days may not be associated with less electrocardiographic abnormalities. Public Library of Science 2016-05-09 /pmc/articles/PMC4861278/ /pubmed/27158908 http://dx.doi.org/10.1371/journal.pntd.0004651 Text en © 2016 Colantonio et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Colantonio, Lisandro D.
Prado, Nilda
Segura, Elsa L.
Sosa-Estani, Sergio
Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
title Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
title_full Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
title_fullStr Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
title_full_unstemmed Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
title_short Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
title_sort electrocardiographic abnormalities and treatment with benznidazole among children with chronic infection by trypanosoma cruzi: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861278/
https://www.ncbi.nlm.nih.gov/pubmed/27158908
http://dx.doi.org/10.1371/journal.pntd.0004651
work_keys_str_mv AT colantoniolisandrod electrocardiographicabnormalitiesandtreatmentwithbenznidazoleamongchildrenwithchronicinfectionbytrypanosomacruziaretrospectivecohortstudy
AT pradonilda electrocardiographicabnormalitiesandtreatmentwithbenznidazoleamongchildrenwithchronicinfectionbytrypanosomacruziaretrospectivecohortstudy
AT seguraelsal electrocardiographicabnormalitiesandtreatmentwithbenznidazoleamongchildrenwithchronicinfectionbytrypanosomacruziaretrospectivecohortstudy
AT sosaestanisergio electrocardiographicabnormalitiesandtreatmentwithbenznidazoleamongchildrenwithchronicinfectionbytrypanosomacruziaretrospectivecohortstudy